A significant advance in cancer investigation is arising with the use of nanobodies to re-engage dysfunctional p53. This essential tumor suppressor protein is frequently inactivated in several types of cancer, https://mysocialquiz.com/story7567391/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-tumor-management